Innovent Biologics achieves primary study endpoint for inactive thyroid eye disease antibody

argenx reports positive Phase 2 results for FB102 in coeliac disease

Vir Biotechnology's VIR-5500 receives FDA Fast Track designation for prostate cancer

FDA accepts Bayer's application for KERENDIA in chronic kidney disease without diabetes

WuXi AppTec awarded EcoVadis gold medal for third year

Suzhou Ribo Life Science submits Phase I Clinical Trial Application for RBD3133 in EU

Roche Diagnostics supplies molecular testing instruments to support Ebola response in the DRC

ABIONYX Pharma partners with OLON to prepare CER-001 for regulatory approval and potential commercial supply

Enliven Therapeutics reaches FDA alignment on relcobatinib (ELVN-001) Phase 3 trial design for previously treated CML

Voyager signs cancer research mission management contract

Pillar Biosciences introduces oncoReveal Myeloid v2 Panel

AbbVie and Genmab report positive results from epcoritamab Phase 3 study in diffuse large B-cell lymphoma

Mozart Therapeutics presents MTX-101 clinical and preclinical data at EASD Annual Meeting

Moberg Pharma reports new Phase 3 analyses on terbinafine activity in onychomycosis

GE HealthCare to acquire SOFIE Biosciences for USD945m